October, 2016 | NuView Life Sciences

Oct 25

U.S. Spends an Estimated $7.9 Billion on Negative Breast and Prostate Cancer Tests; NuView Life Sciences Poised to Change Cancer Diagnosis and Treatment

By Karla Jo Helms Press Releases

Traditional methods of diagnosing malignant cancer are invasive, expensive, and not always accurate. Now, a new way to identify cancer cells stands ready to change…

October 2016

U.S. Spends an Estimated $7.9 Billion on Negative Breast and Prostate Cancer Tests; NuView Life Sciences Poised to Change Cancer Diagnosis and Treatment

Categories

Recent Posts

Archives

Contact Address

The most recent press

Quick Links